BRPI0510075A - benzoxazocines and their therapeutic use as monoamine resorption inhibitors - Google Patents

benzoxazocines and their therapeutic use as monoamine resorption inhibitors

Info

Publication number
BRPI0510075A
BRPI0510075A BRPI0510075-5A BRPI0510075A BRPI0510075A BR PI0510075 A BRPI0510075 A BR PI0510075A BR PI0510075 A BRPI0510075 A BR PI0510075A BR PI0510075 A BRPI0510075 A BR PI0510075A
Authority
BR
Brazil
Prior art keywords
optionally substituted
alkyl
unsubstituted
cycloalkyl
alkenyl
Prior art date
Application number
BRPI0510075-5A
Other languages
Portuguese (pt)
Inventor
Andrew Douglas Baxter
Andrea Walmsley
Elena Lasterra
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0408863A external-priority patent/GB0408863D0/en
Priority claimed from GB0408862A external-priority patent/GB0408862D0/en
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of BRPI0510075A publication Critical patent/BRPI0510075A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

BENZOXAZOCINAS E SEU USO TERAPêUTICO COMO INIBIDORES DE REABSORçãO DE MONOAMINA Compostos tendo utilidade terapêutica são da fórmula geral (1) onde R~ 1~ é H, alquila C~ 1~-C~ 6~ opcionalmente substituída por F ou cicloalquila C~ 3~- C~ 6~ ou alquenila C~ 2~-C~ 4~; A é O, CH~ 2~ ou S (O)~ n~ onde n é 0-2; Um entre W, X, Y e Z é N, CH ou CR~ 3~ e os outros são CH; R~ 2~ é heteroarila C~ 5~-C~ 6~, Cicloalquila C~ 5~-C~ 10~ ou cicloalquenila opcionalmente contendo um ou mais heteroátomos selecionados entre O, N e S(O)~ n~ onde n é 0-2, e opcionalmente substituido por R~ 3~; ou um grupo fenila opcionalmente substituído em uma ou mais posições com um ou mais substituintes independentemente selecionados entre halogênio, CN, CF~ 3~, alquila C~ 1~-C~ 6~ e OR~ 1~, ou o grupo fenila é fundido com um anel de cinco ou seis membros que pode ser carbocíclico, heterocíclico (contendo 1-2 heteroátomos selecionados entre O, N e S), aromático ou heteroaromático (contendo 1-2 heteroátomos selecionados de O e N); R~ 3~ é selecionado dentre halogênio; CF~ 3~; CN; OR~ 5~; SO~ 2~N (R~ 5~)~ 2~; COR~ 5~; CO~ 2~R~ 5~; CON(R~ 5~)~ 2~; NR~ 1~COR~ 4~; NR~ 1~SO~ 2~R~ 4~; NR~ 1CO~ 2~R~ 4~; NR~ 1~CON(R~ 5~)~ 2~; alquila OC~ 1~-C~ 6~ substituída com R~ 3~; alquila C~ 1~-C~ 6~ opcionalmente substituída com R~ 3~ não substituído; cicloalquila C~ 3~-C~ 5~ opcionalmente substituída com R~ 3~ não substituído; alquenila C~ 2~-C~ 6~ opcionalmente substituído com R~ 3~ não substituído; alquinila C~ 2~-C~ 6~ opcionalmente substituído com R~ 3~ não substituído; arila opcionalmente substituída com R~ 3~ não substituído; e heterociclos aromáticos com cinco ou seis membros contendo 1-4 heteroátomos selecionados entre N e O; R~ 4~ é alquila C~ 1~-C~ 6~, alquenila C~ 2~-C~ 6~, alquinila C~ 2~-C~ 6~, cicloalquila C~ 3~-C~ 6~, arila e heteroarila; e R~ 5~ é H, alquila C~ 1~-C~ 6~, alquenila C~ 2~-C~ 6~, alquinila C~ 2~-C~ 6~, cicloalquila C~ 3~-C~ 6~, arila ou heteroarila e é igual ou diferente de outro R~ 5~; ou um sal farmacêuticamente aceitável do mesmo.BENZOXAZOCINS AND THEIR THERAPEUTIC USE AS MONOAMINE REHABORATION INHIBITORS Compounds having therapeutic utility are of the general formula (1) where R 1 is H, C 1 -C 6 alkyl optionally substituted by F or C 3 cycloalkyl -C6- or C2-6 alkenyl; A is O, CH ~ 2 ~ or S (O) ~ n ~ where n is 0-2; One of W, X, Y and Z is N, CH or CR 3 and the others are CH; R 2 is C 5 -C 6 heteroaryl, C 5 -C 10 cycloalkyl or cycloalkenyl optionally containing one or more heteroatoms selected from O, N and S (O) ~ n ~ where n is 0-2, and optionally substituted by R3-; or a phenyl group optionally substituted at one or more positions with one or more substituents independently selected from halogen, CN, CF-3 ~, C1-C6-alkyl and OR-1 ~, or the phenyl group is fused with a five or six membered ring which may be carbocyclic, heterocyclic (containing 1-2 heteroatoms selected from O, N and S), aromatic or heteroaromatic (containing 1-2 heteroatoms selected from O and N); R3 is selected from halogen; CF ~ 3 ~; CN; OR ~ 5 ~; SO ~ 2 ~ N (R ~ 5 ~) ~ 2 ~; COR ~ 5 ~; CO ~ 2 ~ R ~ 5 ~; CON (R 5 ~) ~ 2 ~; NR ~ 1 ~ COR ~ 4 ~; NR ~ 1 ~ SO ~ 2 ~ R ~ 4 ~; NR ~ 1CO ~ 2 ~ R ~ 4 ~; NR ~ 1 ~ CON (R ~ 5 ~) ~ 2 ~; C1-6 alkyl substituted with R3; C1 -C6 alkyl optionally substituted with unsubstituted R3; C3 -C5 cycloalkyl optionally substituted with unsubstituted R3; C 2 -C 6 alkenyl optionally substituted with unsubstituted R 3; C 2 -C 6 alkynyl optionally substituted with unsubstituted R 3; optionally substituted aryl with unsubstituted R3; and five- or six-membered aromatic heterocycles containing 1-4 heteroatoms selected from N and O; R4 is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, aryl and heteroaryl; and R5 is H, C1 -C6 alkyl, C2 -C6 alkenyl, C2 -C6 alkynyl, C3 -C6 cycloalkyl aryl or heteroaryl and is the same or different from another R 5; or a pharmaceutically acceptable salt thereof.

BRPI0510075-5A 2004-04-21 2005-04-21 benzoxazocines and their therapeutic use as monoamine resorption inhibitors BRPI0510075A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0408863A GB0408863D0 (en) 2004-04-21 2004-04-21 Novel benzoxazocines
GB0408862A GB0408862D0 (en) 2004-04-21 2004-04-21 Novel benzoxazocines
PCT/GB2005/001519 WO2005103019A1 (en) 2004-04-21 2005-04-21 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors

Publications (1)

Publication Number Publication Date
BRPI0510075A true BRPI0510075A (en) 2007-10-16

Family

ID=34965745

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510075-5A BRPI0510075A (en) 2004-04-21 2005-04-21 benzoxazocines and their therapeutic use as monoamine resorption inhibitors

Country Status (8)

Country Link
EP (1) EP1740558A1 (en)
JP (1) JP2007533718A (en)
AU (1) AU2005235786A1 (en)
BR (1) BRPI0510075A (en)
CA (1) CA2558741A1 (en)
IL (1) IL177750A0 (en)
NO (1) NO20065057L (en)
WO (1) WO2005103019A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504960D0 (en) * 2005-03-10 2005-04-20 Arakis Ltd Benzoxazocines
GB0506835D0 (en) * 2005-04-04 2005-05-11 Arakis Ltd Therapeutic use of nefopam
BR112012014471A2 (en) 2009-12-15 2017-06-06 Hospital For Sick Children Method for treating scars and beta-catenin-mediated disorders using nefopam compounds
ES2603032T3 (en) 2010-07-15 2017-02-23 Bayer Intellectual Property Gmbh 3-Pyridyl-heteroarylcarboxamide compounds as pesticides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830803A (en) * 1965-05-10 1974-08-20 Riker Laboratories Inc 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones
US3978085A (en) * 1975-03-07 1976-08-31 Riker Laboratories, Inc. Process for benz[f]-2,5-oxazocines
JPS5913770A (en) * 1982-07-13 1984-01-24 Sanwa Kagaku Kenkyusho:Kk Novel 1-phenyl-2,5-benzothiazocine derivative and its preparation
JPS5913760A (en) * 1982-07-13 1984-01-24 Sanwa Kagaku Kenkyusho:Kk Novel benzazocine derivative and its preparation
JP4907818B2 (en) * 1999-11-03 2012-04-04 エーエムアール テクノロジー インコーポレイテッド Aryl and heteroaryl substituted tetrahydroisoquinolines and their use to prevent reuptake of norepinephrine, dopamine and serotonin
EP1572672B1 (en) * 2002-12-20 2008-08-13 Sosei R&D Ltd. Benzoxazocines and their use as monoamine-reuptake inhibitors

Also Published As

Publication number Publication date
NO20065057L (en) 2006-11-21
JP2007533718A (en) 2007-11-22
AU2005235786A1 (en) 2005-11-03
CA2558741A1 (en) 2005-11-03
WO2005103019A1 (en) 2005-11-03
IL177750A0 (en) 2006-12-31
EP1740558A1 (en) 2007-01-10

Similar Documents

Publication Publication Date Title
ATE398125T1 (en) QUINAZOLINE DERIVATIVES AS TGF BETA INHIBITORS
EA200970461A1 (en) SUBSTITUTED DERIVATIVES 3-ISOBUTYL-9,10-DIMETOXI-1,3,4,6,7,11b-HEXAHYDRO-2H-PYRIDO [2,1-a] IZOHINOLIN-2-OLA AND RELATED METHODS
CY1110317T1 (en) 3-Substituted-4-Pyrimidone Derivative
AR058077A1 (en) DERIVATIVES OF PHENOXYACETIC ACIDS
AR052458A1 (en) AMINO-IMIDAZOLONAS FOR THE INHIBITION OF BETA-SECRETASA
BR122017028096B8 (en) compound, pharmaceutical composition, and use of the compound
AR054560A1 (en) SPIROPIPERIDINE AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
BRPI0506817A (en) selective kinase inhibitors
DE602006011752D1 (en) PHENYLGLYCINAMIDE AND PYRIDYLGLYCINAMIDE DERIVATIVES SUITABLE AS ANTICOAGULATING AGENTS
AR055592A1 (en) DERIVATIVES OF 2-AMINO-5-CYCLALKYL-HYDANTOINE AS MODULATORS AND / OR INHIBITORS OF BETA-SECRETASE (BACE)
AR055878A1 (en) CYCLOPROPANOCARBOXAMIDE DERIVATIVES
AR056691A1 (en) PIRROLOPIRIMIDINE DERIVATIVES AS SYK INHIBITORS
AR056536A1 (en) COMPOUNDS OF 2-AMINO-5- [4- (DIFLUORMETOXI) PHENYL] -5-PHENYLIMIDAZOLONE AS INHIBITORS OF THE BETA SECRETASE (BACE)
ATE556058T1 (en) 1-(2H)-ISOCHINOLOONE DERIVATIVE
CO6341631A2 (en) DERIVATIVES OF 1,2,4 - OXADIAZOL AND ITS THERAPEUTIC USE
NO20053449L (en) 3-substituted 4-pyrimidone derivatives
NO20075384L (en) Tiadiazole-substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitors.
ECSP099335A (en) HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN AND METHODS OF USE OF THE SAME
CY1114767T1 (en) N, N-Substituted 3-Aminopyrrolidine Compounds Useful as Monoamines Reflux Inhibitors
NO20061317L (en) Imidazopyridine derivatives as inducible NO synthase inhibitors
PE20070212A1 (en) 1,4-DIHYDROPYRIDINE-CONDENSED HETEROCYCLES, PROCESSES TO PREPARE THE SAME, USE AND COMPOSITIONS CONTAINING THEM
NO20076680L (en) Selected CGRP antagonists, methods for their preparation and their use as drugs
NO20080033L (en) Quinoline derivatives as NK3 antagonists
EA200971062A1 (en) DERIVATIVES OF ARYLAMIDPYRIMIDONE
AR042362A1 (en) DERIVATIVES OF 3H-QUINAZOLIN-4-ONA, PROCESS OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.